Back to top
more

Herbalife Ltd (HLF)

(Real Time Quote from BATS)

$9.11 USD

9.11
637,931

-0.14 (-1.51%)

Updated Aug 7, 2025 10:32 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 41% (100 out of 246)

Industry: Retail - Pharmacies and Drug Stores

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Urmimala Biswas headshot

CVS Q2 Estimates Dip: Is the Stock Still a Buy Ahead of Q2 Earnings?

by Urmimala Biswas

Earnings estimates for CVS dip ahead of Q2 results, but turnaround efforts in Aetna and PBM strength may offset pressure.

Urmimala Biswas headshot

CVS Surges on Regulatory Relief, Medicare Advantage Push: Time to Buy?

by Urmimala Biswas

CVS surges 53.7% YTD as regulatory relief, strong execution and Medicare Advantage momentum fuel investor confidence.

Zacks Equity Research

Are Retail-Wholesale Stocks Lagging Allbirds, Inc. (BIRD) This Year?

by Zacks Equity Research

Here is how Allbirds, Inc. (BIRD) and Herbalife Ltd (HLF) have performed compared to their sector so far this year.

Zacks Equity Research

Is Allbirds, Inc. (BIRD) Stock Outpacing Its Retail-Wholesale Peers This Year?

by Zacks Equity Research

Here is how Allbirds, Inc. (BIRD) and Herbalife Ltd (HLF) have performed compared to their sector so far this year.

Zacks Equity Research

Herbalife and Abercrombie and Fitch have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Herbalife earns Bull of the Day with estimate hikes and strong beats while Abercrombie and Fitch lands Bear as earnings revisions turn negative.

Brian Bolan headshot

Bull Of The Day: Herbalife (HLF)

by Brian Bolan

A big move yesterday could just be the start of things for this stock on the comeback trail.

Urmimala Biswas headshot

CVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?

by Urmimala Biswas

CVS' pharmacy segment continues to lead the industry, processing over 1.7 billion prescriptions annually while delivering high medication adherence.

Zacks Equity Research

How Much Upside is Left in Herbalife Ltd (HLF)? Wall Street Analysts Think 28.83%

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 28.8% in Herbalife Ltd (HLF). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Equity Research

Are Retail-Wholesale Stocks Lagging Herbalife Ltd (HLF) This Year?

by Zacks Equity Research

Here is how Herbalife Ltd (HLF) and Next PLC (NXGPY) have performed compared to their sector so far this year.

Zacks Equity Research

New Strong Buy Stocks for May 5th

by Zacks Equity Research

WGS, NWG, HLF, CALM and ESEA have been added to the Zacks Rank #1 (Strong Buy) List on May 5, 2025.

Zacks Equity Research

Best Value Stocks to Buy for May 5th

by Zacks Equity Research

HLF, CALM and ESEA made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 5, 2025.

Zacks Equity Research

Best Growth Stocks to Buy for May 2nd

by Zacks Equity Research

LTM, HLF and BGC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 2, 2025.

Zacks Equity Research

Best Value Stocks to Buy for May 2nd

by Zacks Equity Research

HLF, LTM and BCS made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 2, 2025.

Zacks Equity Research

Is Herbalife Ltd (HLF) Stock Outpacing Its Retail-Wholesale Peers This Year?

by Zacks Equity Research

Here is how Herbalife Ltd (HLF) and Portillo's Inc. (PTLO) have performed compared to their sector so far this year.

Urmimala Biswas headshot

CVS Soars 53% in Q1: Time to Buy the Stock Ahead of Earnings Release?

by Urmimala Biswas

Caremark, CVS Health's PBM business, is expected to have continued to play a vital role in offsetting the rising cost of branded drugs during the first quarter.

Urmimala Biswas headshot

CVS Health Takes the Lead in 2025 S&P 500 Chart: Is It a Buy Now?

by Urmimala Biswas

CVS Health's strong track record of stable cash generation aids it amid the broader market sell-offs due to escalating 2025 Trump tariffs.

Zacks Equity Research

Are Retail-Wholesale Stocks Lagging Herbalife Ltd (HLF) This Year?

by Zacks Equity Research

Here is how Herbalife Ltd (HLF) and Alibaba (BABA) have performed compared to their sector so far this year.

Zacks Equity Research

Are Retail-Wholesale Stocks Lagging Herbalife Ltd (HLF) This Year?

by Zacks Equity Research

Here is how Herbalife Ltd (HLF) and MercadoLibre (MELI) have performed compared to their sector so far this year.

Urmimala Biswas headshot

CVS Stock Soars 47% YTD: Is Digital Growth Fueling a Buy Opportunity?

by Urmimala Biswas

CVS Health is consistently increasing investments in fast-growing spaces like enterprise data platforms, cloud capabilities and digital products.

Zacks Equity Research

What Makes Herbalife Ltd (HLF) a New Strong Buy Stock

by Zacks Equity Research

Herbalife Ltd (HLF) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Best Growth Stocks to Buy for February 26th

by Zacks Equity Research

DAN, HLF and PAX made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 26, 2025.

Zacks Equity Research

Is Herbalife Ltd (HLF) Stock Outpacing Its Retail-Wholesale Peers This Year?

by Zacks Equity Research

Here is how Herbalife Ltd (HLF) and Potbelly (PBPB) have performed compared to their sector so far this year.

Zacks Equity Research

Best Value Stocks to Buy for February 26th

by Zacks Equity Research

HLF, XHR and PAX made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 26, 2025.

Zacks Equity Research

Best Momentum Stock to Buy for February 26th

by Zacks Equity Research

GRMN, LNVGY and HLF made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 26, 2025.

Urmimala Biswas headshot

CVS Health Post-Q4 Earnings: Is the Stock Worth Buying Now?

by Urmimala Biswas

CVS Health's adjusted EPS outlook for 2025 reflects expectations of a meaningful recovery in Medicare Advantage and continued growth in Health Services.